During pathogen infection, antibodies can be carried into the infected cell, where they are detected by the ubiquitously expressed cytosolic antibody receptor TRIM21. Here we found that recognition of intracellular antibodies by TRIM21 activated immune signaling. TRIM21 catalyzed the formation of Lys63 (K63)-linked ubiquitin chains and stimulated the transcription factor pathways of NF-kB, AP-1, IRF3, IRF5 and IRF7. Activation resulted in the production of proinflammatory cytokines, modulation of natural killer stress ligands and induction of an antiviral state. Intracellular antibody signaling was abrogated by genetic deletion of TRIM21 and was restored by ectopic expression of TRIM21. The sensing of antibodies by TRIM21 was stimulated after infection by DNA or RNA nonenveloped viruses or intracellular bacteria. Thus, the antibody-TRIM21 detection system provides potent, comprehensive activation of the innate immune system independently of known pattern-recognition receptors.
A r t i c l e s
The sensing of intracellular pathogens is critical to the immune response. Known methods of detection rely on the recognition of pathogen-associated molecular patterns (PAMPs) by germlineencoded pattern-recognition receptors (PRRs) such as Toll-like receptors (TLRs) 1 and the cytoplasmic nucleic-acid receptors RIG-I and Mda5 (refs. 2,3) . Alternatively, the host may sense physiological changes that accompany infection by a pathogen or sterile injury through the detection of danger-associated molecular patterns (DAMPs) 4 . DAMPs are host-derived molecules that, when detected in a specific context, can induce an inflammatory response 5 . In the noninflammatory resting state, the location of DAMPs must be tightly regulated. For example, antibodies patrol the extracellular spaces and mediate extracellular immune responses.
Antibodies can also be carried into cells when attached to particles of an infecting virus 6 . Once inside the cell, antibody-coated viruses are bound by the cytosolic antibody receptor TRIM21 via its carboxy (C)-terminal PRYSPRY domain. The binding affinity of TRIM21 to antibody is subnanomolar, which makes TRIM21 the human Fc receptor (FcR) with the highest affinity 7 . After binding incoming virus-antibody complexes in the cytoplasm, TRIM21 targets virions for degradation, a process that is dependent on both the proteasome 6 and the ATPase and unfoldase VCP 8 . This process is known as 'antibody-dependent intracellular neutralization' (ADIN) 9 . Depletion of TRIM21 prevents efficient neutralization of adenovirus by pooled human serum immunoglobulin G (IgG) 6 . Conversely, high expression of TRIM21 permits neutralization by fewer than two antibody molecules per virus particle 10 . TRIM21 is a close homolog of TRIM5α, which restricts infection by retroviruses in a species-specific manner 11 . Human TRIM5α responds to infection with restricted viruses by synthesizing unanchored Lys63 (K63)-linked ubiquitin chains 12 . That activity stimulates the downstream kinase TAK1, which results in a signaling cascade that activates the transcription factors NF-κB and AP-1.
In this study we sought to determine whether antibody entering the cytoplasm while bound to a pathogen acts in a contextdependent manner to initiate immune signaling. We found that cytoplasmic antibodies were potent DAMPs and that TRIM21 was necessary for detection. TRIM21 synthesized unanchored K63-linked ubiquitin chains in a RING domain-dependent manner. Incoming virus-antibody complexes activated NF-κB, AP-1 and IRF signaling pathways, which resulted in the production of proinflammatory cytokines and the induction of an antiviral state. TRIM21 signaling was not pathogen specific, as nonenveloped viruses and bacteria, as well as antibody-coated latex beads, were able to elicit signaling. Our findings demonstrate the existence of a potent detection mechanism that allows cells to stimulate broad-spectrum immunity after penetration of their cytosol by antibody-bound pathogens.
RESULTS

Detection of adenovirus-antibody complexes elicits NF-kB signaling
To determine whether antibody entering the cytoplasm while bound to a pathogen initiates immune signaling, we assayed activated NF-κB subunits p65, p50 and p52 at 4 h after challenge with an adenovirus type 5 vector (AdV) preincubated with antibody (AdV-antibody complex). We analyzed activation by detection of binding of NF-κB subunits to DNA oligonucleotides containing the consensus NF-κB-binding site by enzyme-linked immunosorbent assay (ELISA). In wild-type mouse embryonic fibroblasts (MEFs), we observed substantial activation of NF-κB after infection with AdVantibody complex but not with either component alone ( Fig. 1a  and Supplementary Fig. 1) . The response was dependent on TRIM21, as we did not observe activation in MEFs derived from A r t i c l e s TRIM21-deficient mice. Furthermore, activation in TRIM21-deficient MEFs was restored by ectopic expression of human TRIM21 ( Fig. 1a and Supplementary Fig. 1) . 'Titration' of AdV, antibody or AdVantibody complex onto wild-type and TRIM21-deficient MEFs showed that activation of an NF-κB luciferase reporter was dose dependent and approached saturation at high multiplicity of infection but was absent at all multiplicities of infection in TRIM21-deficient MEFs (Fig. 1b) . TRIM21 was not required for constitutive NF-κB signaling in response to other stimuli, as we observed similar activation in wild-type MEFs and TRIM21-deficient MEFs transduced to express empty vector or human TRIM21 after challenge with lipopolysaccharide (LPS) or tumor-necrosis factor (TNF) ( Fig. 1c and Supplementary Fig. 1) . These results demonstrated that TRIM21 detected intracellular AdV-antibody complex and activated NF-κB signaling.
TRIM21 recognizes antibodies of diverse species origin and class
The TRIM21-IgG molecular interaction and ADIN are conserved among mammalian species 10, 13 . HeLa human cervical cancer cells infected with AdV preincubated with human serum IgG activated NF-κB ( Fig. 1d) , which suggested that TRIM21 signaling was similarly conserved. AdV-antibody complex induced an amount of signaling similar to that induced by TNF, whereas we observed poor activation in cells depleted of TRIM21 or challenged with virus or antibody alone. Furthermore, cells of human origin (HeLa cells) and mouse origin (MEFs) responded to both conspecific and heterospecific antibodies ( Supplementary Fig. 2 ). Early-stage humoral immune responses are governed by IgM, which also interacts with TRIM21 (ref. 6) . We observed stimulation of NF-κB by a complex of AdV and human IgM, but not by either component alone, similar to results obtained with IgG ( Fig. 1e) . We observed no such stimulation in TRIM21-deficient MEFs (Fig. 1e) , which confirmed that recognition of IgM by TRIM21 was able to initiate signaling. These data demonstrated that the detection of IgG by TRIM21 was conserved in humans and mice and was able to respond to antibodies of diverse species origin. Moreover, TRIM21 was able to detect the antibody classes IgG and IgM.
Detection requires direct TRIM21-Fc molecular interaction
Substitution of amino acids at the binding interface between TRIM21 and IgG prevents their interaction and disrupts intracellular neutralization 10, 13 . To demonstrate that direct TRIM21-antibody interactions are also required for signaling, we replaced the asparagine at position 434 with aspartic acid (N434D) in monoclonal antibody 9C12, which binds to the major adenovirus capsid protein hexon. Asn434 is a residue in the Fc region of the IgG heavy chain that interacts with TRIM21 ( Fig. 1f) . NF-κB luciferase response after challenge with the mutant N434D antibody was impaired relative (K21 EV)  or vector expressing human TRIM21 (K21 T21) with PBS, AdV, human serum IgG (hIgG) or AdV-human serum IgG complex (AdV-hIgG); results are presented relative to those of PBS-challenged cells. (b) NF-κB luciferase activity in wild-type or TRIM21-deficient (K21) MEFs 7 h after challenge with a serial dilution of AdV, goat polyclonal antibody to adenovirus (gtAb) or AdV-goat antibody complex (AdV-gtAb); results are presented relative to the activity in PBS-treated control cells. (c) NF-κB luciferase activity in wild-type cells, TRIM21deficient MEFs and TRIM21-deficient MEFs expressing human TRIM21, treated with AdV-human IgG complex, TNF or LPS; results are presented relative to the activity in PBS-treated control cells. (d) NF-κB luciferase activity in HeLa cells transfected with nontargeting control siRNA (NC si) or TRIM21-specific siRNA (T21 si) and challenged as in a or with TNF; presented as in c. (e) NF-κB luciferase activity in TRIM21-deficient MEFs transduced as in a and challenged with AdV, human serum IgM (hIgM) or AdV-human serum IgM complex (AdV-hIgM); presented as in c. (f) 'Hot-spot' interactions between IgG Fc (cyan) and the TRIM21 PRYSPRY domain (yellow) required for complex formation (based on Protein Data Bank structure 2IWG). (g) NF-κB luciferase activity in wild-type MEFs challenged with recombinant 9C12 (r9C12) or its N434D form (r9C12 ND), either alone or in complex with AdV; presented as in c. (h) NF-κB luciferase activity in EL4 cells (EL4) and CAR-expressing EL4 cells (EL4 CAR) 7 h after challenge as in a or with LPS or TNF; presented as in c. Data are representative of three experiments (error bars (a-e,g,h), s.e.m. of three replicates). NF-κB induction (fold) A r t i c l e s to that obtained with wild-type recombinant 9C12 ( Fig. 1g) .
To demonstrate that infection, rather than a cell-surface interaction, was required for TRIM21-mediated signaling, we used the mouse lymphoma cell line EL4, which does not permit AdV infection, and EL4 cells stably transduced to express the receptor CAR, which renders the cells permissive to AdV infection ( Supplementary  Fig. 3 ). We observed induction of NF-κB luciferase activity in both cell lines in response to LPS or TNF, but only cells expressing CAR were responsive to challenge with AdV-antibody complex ( Fig. 1h) . We therefore concluded that an intracellular molecular interaction between IgG and TRIM21 was required for signaling in response to AdV-antibody complex.
Signaling depends on the TRIM21 RING domain TRIM5α has been shown to activate the AP-1 and NF-κB signaling pathways, both constitutively in the LPS stimulation pathway and after infection with retroviruses, by catalyzing the formation of free K63-linked ubiquitin chains 12 . In the presence of the K63-specific E2 ubiquitin-conjugating enzymes Ubc13 and UEV1A, we found that TRIM21 catalyzed the formation of K63-linked chains in vitro ( Fig. 2a) . Both TRIM21 and the E2 ubiquitin-conjugating enzymes remained unmodified ( Fig. 2a and Supplementary Fig. 4 ), which suggested that the resulting chains were unanchored. We observed the formation of ubiquitin chains with wild-type or K63-only ubiquitin but not with ubiquitin in which the lysine at position 63 was replaced with arginine ( Fig. 2b) , which confirmed that the linkage was through Lys63. Ubiquitination was dependent on the RING domain ( Fig. 2c ) and, accordingly, TRIM21 signaling was RING dependent, as TRIM21-deficient MEFs expressing human TRIM21 lacking the RING domain did not activate NF-κB after challenge with AdV-antibody complex (Fig. 2d) . However, TRIM21 signaling, but not in vitro ubiquination activity, was dependent on the PRYSPRY domain ( Fig. 2c,d) . This was suggestive of a greater complexity of TRIM21 activation in cells than in the in vitro system. Depletion of Ubc13 through the use of small interfering RNA (siRNA) resulted in substantially less activation of NF-κB in response to AdV-antibody complex in both MEF and HeLa cells ( Fig. 2e,f) . We also observed diminished activation after challenge with TNF ( Supplementary  Fig. 5 ), a finding in accordance with the reported involvement of Ubc13 in signaling via the TNF receptor 14 . Together these data showed that TRIM21 catalyzed the formation of K63-linked ubiquitin chains in a RING-dependent manner and that deletion of the RING or depletion of the E2 K63-linked ubituitin-conjugating enzyme Ubc13 prevented efficient signaling in response to infection with antibodycoated AdV.
TRIM21 signals via the NF-kB, AP-1 and IRF pathways K63-linked ubiquitin chains can promote signaling via the kinase complexes TAK1-TAB1-TAB2 (refs. 12, 15) and IKKα-IKKβ-NEMO 16, 17 .
To determine whether those complexes are activated by TRIM21, we used inhibitors of TAK1 (5Z-7-oxozeaenol) and IKKα-IKKβ (IKK VII). We also used an inhibitor of the NF-κB pathway at its downstream component IκB (panepoxydone). NF-κB signaling in response to AdV-antibody complex was suppressed after treatment with any of the three inhibitors ( Fig. 3a) , which confirmed the involvement of both kinase complexes. Next we analyzed the phosphorylation state of individual components of the pathways. After challenge with AdV-antibody complex, we observed more phosphorylated IKKα and NF-κB p65 in wild-type MEFs but not in TRIM21-deficient MEFs (Fig. 3b) . Activation of the TAK1 complex can also stimulate the AP-1 transcriptional complex, which is composed of dimers of members of the Jun and Fos families. To determine whether the AP-1 pathway was also stimulated by TRIM21, we measured the ability of members of the Fos and Jun families to interact with the TPA (12-o-tetradecanoylphorbol-13-acetate)-response element by DNA-binding ELISA. We found that Fos-B, c-Jun and JunD bound oligonucleotides containing that element only in MEFs expressing TRIM21 when stimulated by AdVantibody complex, but not in their TRIM21-deficient counterparts ( Fig. 3c) . Notably, activation of c-Fos was not TRIM21 dependent and was stimulated by AdV alone and by AdV-antibody complex, indicative of the activity of other PRRs (Fig. 3c) . Furthermore c-Jun was phosphorylated after challenge with AdV-antibody complex in MEFs expressing TRIM21 but not in TRIM21-deficient MEFs (Fig. 3d) . TRIM21 is reported to modulate the activity of IRF transcription --------K63R K63 only   160  110  80  60  50  40  30   20   15   260  160  80  60  40   30   20 15 IB: Ub IB: Ub IB: Ub
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Ubc13 si2 NF-κB induction (fold) A r t i c l e s factors both positively 18, 19 and negatively [20] [21] [22] . We determined whether the recognition of AdV-antibody complex by TRIM21 was able to stimulate IRF proteins by DNA-binding ELISA. We found that IRF3, IRF5 and IRF7 were specifically activated by AdV-antibody complex in a TRIM21-dependent manner, but IRF8 was not ( Fig. 3e) . Together our data suggested that the recognition of AdV-antibody complex by TRIM21 stimulated the three principal signaling pathways of NF-κB, AP-1 and IRF.
TRIM21 signaling elicits a proinflammatory response
To determine whether recognition of intracellular antibody by TRIM21 was sufficient to stimulate an inflammatory immune response, we compared the expression of cytokines in wild-type and TRIM21-deficient MEFs after challenge with AdV-antibody complex. We observed a 100-to 10,000-fold greater abundance of transcripts encoding interleukin 6 (IL-6) and the chemokines CXCL10, CCL2 and CCL4 in wild-type cells after challenge with AdV-antibody complex, with much less induction by either component alone (Fig. 4a) . The abundance of cytokine mRNA was 10-to 1,000-fold higher in wild-type MEFs than in TRIM21-deficient MEFs after challenge with AdV-antibody complex, whereas treatment with the double-stranded RNA analog poly(I:C) produced similar induction in wild-type and TRIM21-deficient MEFs (Fig. 4a) . Transcriptional upregulation in wild-type MEFs challenged with AdV-antibody complex was accompanied by protein production of the cytokines IL-6, CCL4 and TNF (Fig. 4b) . Moreover, ectopic expression of TRIM21 in TRIM21deficient MEFs was sufficient to restore cytokine expression in response to challenge with AdV-antibody complex (Fig. 4c) .
We determined if the production of cytokines was dependent on the NF-κB signaling pathway by infecting wild-type MEFs in the presence of the IκB inhibitor panepoxydone. Addition of the inhibitor prevented substantial production of IL-6 after challenge with AdV-antibody complex (Fig. 4d) . In addition, we tested whether the RING and PRYSPRY domains of TRIM21 were required for cytokine production. Expression of full-length TRIM21 was sufficient to restore IL-6 production in TRIM21-deficient MEFs challenged with AdV-antibody complex, whereas empty vector or expression of TRIM21 constructs lacking the RING or PRYSPRY domain was not ( Fig. 4e) .
Signaling by TRIM21 was also sufficient to induce interferon production. Challenge of wild-type MEFs with AdV-antibody complex resulted in upregulation of interferon-β (IFN-β) expression; in contrast, we observed little upregulation in TRIM21-deficient MEFs (Fig. 4f) . These results demonstrated that TRIM21-mediated detection of antibody-bound antigen induced a proinflammatory state in the cells.
Activation of TRIM21 triggers an antiviral state
The antiviral state encompasses changes in cell physiology that diminish viral infection and replication and flag infected cells for destruction by leukocytes. For example, infected cells can stimulate effector T cells and natural killer cells by upregulating the expression of major histocompatibility complex (MHC) class I and MHC class I-like cell surface molecules such as NKG2 ligands 23 . We investigated whether activation of TRIM21 was sufficient to trigger such an antiviral state. Infection with AdV-antibody complex resulted in TRIM21-dependent 
c c-Jun and JunD (fold) Fig. 5a ). Challenge of wild-type MEFs with AdV-antibody complex resulted in higher expression of MHC class Ia H2-D b than did PBS treatment (Fig. 5b) .
In contrast, there was no substantial change in TRIM21-deficient MEFs or in wildtype MEFs treated with AdV or antibody alone (Fig. 5b) .
To determine whether the cytokines produced after stimulation with TRIM21 were sufficient to diminish viral infection, we transferred supernatants from wild-type and TRIM21-deficient MEFs that had been challenged with PBS, antibody, AdV or AdV-antibody complex onto fresh 'reporter' MEFs. As a measure of the permissiveness of the host cell to viral infection, we challenged reporter cells with a Sindbis virus-green fluorescent protein (GFP) vector that is inhibited after treatment with IFN-α. Supernatants from wild-type MEFs challenged with AdVantibody complex diminished the infection of reporter MEFs by the Sindbis-GFP vector to a degree similar to that achieved by treatment with IFN-α ( Fig. 5c,d) . In contrast, supernatants of TRIM21-deficient cells did not substantially diminish the infectivity of reporter MEFs. These data demonstrated that the cytokines produced after stimulation of TRIM21 were sufficient to confer an antiviral state.
TRIM21 expression is upregulated after treatment with IFN-α, which affords the ability to experimentally alter the process of ADIN 10 . The transfer of supernatants of TRIM21-deficient MEFs that had been treated with PBS only or with AdV-antibody complex onto fresh reporter MEFs did not alter the amount of neutralization of AdV, as measured by the infectious titer of PBS-treated AdV divided by the titer of antibody-treated AdV (Fig. 5e) . However, the transfer of supernatants from wild-type cells that had been challenged with AdVantibody complex resulted in substantially more neutralization in wild-type reporter MEFs. The enhanced neutralization was the result of the activity of TRIM21 as an effector of ADIN, as we observed no greater neutralization when we used TRIM21-deficient MEFs as the reporter cells. These experiments suggested that TRIM21 signaling induced by antibody-bound AdV resulted in more TRIM21-dependent neutralization of the same pathogen.
Cells in S phase provide optimal conditions for viral replication 24 . Activation of the AP-1 and IRF pathways or cytokine production can induce cell-cycle arrest [25] [26] [27] . We determined, by propidium iodide staining, whether stimulation of TRIM21 altered the proportion of cells in the G1, S and G2 phases of the cell cycle. We observed fewer wild-type MEFs in S phase after challenge with AdV-antibody complex ( Fig. 5f) . However, antibody 9C12 bearing the N434D substitution, which was unable to induce TRIM21 signaling, did not elicit such a change. Together these experiments showed that stimulation of TRIM21 rendered cells refractory to viral infection and modulated the expression of cell surface ligands recognized by professional cells of the immune system.
TRIM21 recognizes intracellular viruses and bacteria
Next we investigated whether TRIM21 signaling is pathogen dependent. We reasoned that an antibody-bound pathogen accessible in the cytoplasm should elicit signaling, whereas a pathogen that sheds its antibody before penetrating the cytosol should not. We chose two contrasting A r t i c l e s viruses to test our hypothesis: the nonenveloped feline calicivirus (FCV), which may carry antibodies with it into the cell after infection; and the enveloped respiratory syncytial virus (RSV), which fuses at or near the plasma membrane 28 and should lose its attached antibodies during membrane fusion. FCV activated an NF-κB luciferase reporter in the presence of pooled feline serum IgG in wild-type MEFs but not in TRIM21-deficient MEFs (Fig. 6a) . In contrast, infection with RSV preincubated with antibody resulted in similar activation of the NF-κB luciferase reporter in wild-type and TRIM21-deficient MEFs (Fig. 6b) . Similarly, and in contrast to AdV 6,10 , incubation of RSV with neutralizing antibody resulted in similar amounts of neutralization in HeLa cells left untreated or treated with TRIM21-specific siRNA or IFN-α ( Supplementary Fig. 6 ), which suggested that neutralization of RSV was ADIN independent.
To determine whether antibody-coated bacteria can also be sensed by TRIM21, we studied infection by the facultative intracellular bacterium Salmonella enterica serovar Typhimurium, which can reside in vacuoles or in the cytosol 29, 30 . Confocal microscopy showed that Salmonella carried antibodies into the cell after infection and that TRIM21 localized together with a subset of antibody-bound bacteria (Fig. 6c) . Furthermore, infection of HeLa cells with Salmonella elicited antibody-dependent NF-κB signaling that was inhibited after depletion of TRIM21 by siRNA (Fig. 6d) . In MEFs, although we observed TRIM21-and antibody-independent stimulation of NF-κB in response to infection (Fig. 6e) , preincubation of bacteria with antibody resulted in a further increase in signaling in wild-type MEFs but not in TRIM21deficient MEFs (Fig. 6f) . Infection with ∆SifA Salmonella, a strain that loses vacuolar integrity, which results in a greater proportion of bacteria in the cytosol 31, 32 , stimulated greater activation of NF-κB than did infection with wild-type Salmonella when coated with antibody ( Fig. 6f) . The signaling induced by ∆SifA Salmonella was dependent on TRIM21 and antibody and exceeded the signaling induced by bacteria alone at all concentrations assayed (Fig. 6g) . Together these data suggested that TRIM21 was able to activate innate immune signaling after sensing any cytosolic antibody-bound pathogen.
TRIM21 signaling is independent of FcRs, PRRs and ADIN
To exclude the possibility that the signaling we observed was due to the recognition of the AdV-antibody complex by an FcR or innate sensor other than TRIM21, we did infection experiments in the presence or absence of specific inhibitors or knockdown of those pathways. The addition of inhibitors of the adaptors MyD88 and TRIF efficiently blocked signaling in response to LPS (Supplementary Fig. 7) but had no effect on the stimulation of NF-κB by AdV-antibody complex (Fig. 7a) , which confirmed that the signaling was TLR independent. Inhibition of the cytosolic tyrosine kinase Syk prevented signaling in response to crosslinked surface-bound antibody ( Supplementary  Fig. 7) but did not prevent signaling in response to AdV in complex with antibody ( Fig. 7b) , which confirmed that TRIM21 signaling was independent of cell-surface FcRs. Similarly, knockdown of the intracellular nucleic-acid receptors Mda5 and RIG-I did not impair signaling in response to antibody-bound AdV or FCV (Fig. 7c,d) . 
A r t i c l e s
During ADIN, TRIM21 directs incoming virions to the proteasome, which potentially exposes PAMPs that could initiate or promote immune signaling in the cytosol. We investigated whether the signaling we observed was ADIN dependent by inhibiting the proteasome with epoxomicin. Treatment with epoxomicin reversed the neutralization of AdV-antibody complex in wild-type MEFs from approximately 150-fold to 3-fold, and in TRIM21-deficient MEFs, the residual neutralization of 6-fold was almost completely ablated ( Fig. 7e) . Proteasomal function is required for the processing of NF-κB and AP-1 but not for the activation of IRF7. We therefore Fig. 1a and challenged with PBS, AdV, 9C12 or AdV-9C12 complex) after treatment with PBS, control inhibitor (Ctrl) or inhibitors of MyD88 and TRIF (presented as in Fig. 1c ). (b) NF-κB luciferase activity in MEFs (transduced as in Fig. 1a and challenged as in a) after treatment with DMSO or an inhibitor of Syk (presented as in Fig. 1c ).
(c) NF-κB luciferase activity in wild-type or TRIM21-deficient MEFs treated with control or Mda5-or RIG-I-specific siRNA (horizontal axes) and with AdV coated with 9C12 or FCV coated with feline IgG (presented as in Fig. 1b) . Figure 1a and transfected with biotin-labeled beads, antibody to biotin (Anti-biotin) or a complex of beads and antibody (presented as in Fig. 1c ). Data are representative of three experiments (error bars (a-c,e-g), s.e.m. of three replicates).
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A r t i c l e s investigated whether the binding of IRF7 to DNA was preserved during proteasome inhibition in TRIM21-deficient MEFs expressing empty vector or human TRIM21. The addition of epoxomicin did not prevent the activation of IRF7 (Fig. 7f) , which demonstrated that TRIM21 signaling was independent of ADIN and was able to occur under conditions of proteasome inhibition.
The data presented above suggested that the minimum requirement for TRIM21-mediated immune signaling was the presence of antibody in the cytosol. To test this, we transfected cells with biotinlabeled latex beads preincubated with antibody to biotin. Such antibody-coated beads are detected by TRIM21 and become positive for ubiquitin 6 . Transfection of antibody-coated beads stimulated strong induction of an NF-κB reporter in TRIM21-deficient MEFs expressing human TRIM21 (Fig. 7g) . However, we observed no such signaling with either beads or antibody alone or in TRIM21-deficient MEFs transduced with empty vector. This result confirmed that the detection of cytosolic antibody by TRIM21 was sufficient to activate immune signaling independently of PAMPs and ADIN.
TRIM21 activates NF-kB and cytokine production in primary cells
We next investigated immune signaling by TRIM21 in primary cells. Human adenovirus type 5 causes infection of the upper and lower respiratory system 33 . We therefore assessed the infection of primary normal human lung fibroblasts (NHLFs) with AdV-antibody complex. We introduced an NF-κB reporter into NHLFs by lentiviral transduction and assessed cells depleted of TRIM21 by treatment with TRIM21-specific siRNA or treated with a nonspecific control siRNA (Fig. 8a) . Whereas treatment of the cells with LPS induced activation NF-κB regardless of the amount of TRIM21 present (Fig. 8b) , the response to AdV-antibody complex was significantly lower after depletion of TRIM21 (Fig. 8c) . NHLFs challenged with RSV in complex with antibody resulted in no greater NF-κB activation than that in NHLFs treated with RSV alone (Fig. 8c) , which confirmed that antibody in the cytoplasm was required for such activation. As noted for the infection of MEFs, the TAK1 inhibitor 5Z-7-oxozeaenol, the IKK inhibitor IKK VII and the IκB inhibitor panepoxydone prevented the activation of NF-κB by AdV-antibody complex in NHLFs (Fig. 8d) , which confirmed the involvement of those pathway components. Also similar to the effect in MEFs, inhibition of Syk did not prevent the activation of NF-κB ( Fig. 8d) , which excluded the possibility of activation in NHLFs mediated by FcRs at the cell surface.
To confirm that TRIM21-dependent signaling was sufficient to activate cytokine production in primary cells, we measured the secretion of IL-6 by NHLFs after challenge with AdV. We observed substantial IL-6 production in cells challenged with AdV-antibody complex, and this was diminished in cells depleted of TRIM21 or in which the NF-κB pathway was inhibited ( Fig. 8e) . Of note, infection with adenovirus alone was not sufficient to activate IL-6 secretion in NHLFs (Fig. 8e) , which indicated the potential importance of TRIM21-antibody signaling in the detection of adenovirus in the lung. These experiments demonstrated that the detection of AdV infection in lung fibroblasts was dependent on stimulation of TRIM21 and signaling via TAK1, IKKα and IκB and that activation of NF-κB was a requirement for production of the proinflammatory cytokine IL-6.
Next we examined signaling in primary cells of the immune system. We generated bone marrow-derived macrophages (BMDMs) from monocytes derived from wild-type C57BL/6 or TRIM21deficient mice 34 and prepared them by selection for the common myeloid marker CD11b. To prevent potential FcR-mediated A r t i c l e s responses, we did these experiments in the presence of Fc fragments. Challenge with AdV-antibody complex resulted in the activation of NF-κB in wild-type BMDMs but not in TRIM21-deficient BMDMs, as measured by DNA-binding assays for p65 and p50 (Fig. 8f) . Unlike the results we obtained with other cell types, in BMDMs we observed some activation of NF-κB in response to AdV in the absence of antibody (Fig. 8f) , indicative of the presence of other PRRs in macrophages. However, activation of TRIM21 was required for substantial cytokine production in BMDMs (Fig. 8g) . IL-6, TNF and IL-12 were present in the supernatants of wildtype cells but not those of TRIM21-deficient cells after challenge (Fig. 8g) . These results demonstrated that TRIM21 detected intracellular antibody-bound pathogens in primary cells, including professional cells of the immune system, which led to the production of proinflammatory cytokines.
DISCUSSION
We have shown that antibodies provide a context-dependent danger signal when associated with intracellular pathogens. Cytosolic antibody-bound particles are detected by TRIM21, which triggers immune signaling. We found that TRIM21 catalyzed the formation of free K63 ubiquitin chains via the E2 ubiquitin-conjugating enzyme Ubc13 in a RING-dependent manner and promoted signaling through three key immunological pathways: NF-κB, AP-1 and the IRF family. Activation of those pathways by TRIM21 resulted in the production of proinflammatory cytokines, modulation of cell-surface ligands and adoption of an antiviral state. Sensing of antibodies by TRIM21 occurred in primary leukocytes and primary cells that are the target of pathogen infection. We have defined the minimal requirements for sensing by TRIM21, the mechanism by which this occurs and the characteristics of susceptible pathogens. TRIM21 signaling was independent of its neutralization activity (ADIN), cell-surface FcRs and known PAMPs, such as the TLRs, RIG-1 and Mda5, but was dependent on TAK1, IKKα and IκB. We defined a PAMP-free antibody-bound particle as the minimum requirement to elicit detection, as antibodycoated latex beads were sufficient to induce signaling. The full range of entities that can be detected by TRIM21 remains to be determined. However, we have shown that both nonenveloped viruses and intracellular bacteria were able to carry antibody into the cytosol and were targets of TRIM21. It is possible that other classes of pathogens, such as eukaryotic parasites, are recognized similarly. Given the consequences of recognition, evading detection by TRIM21 may be a requirement for successful invasion by certain pathogens. We have shown that features of the virus life cycle, such as the cell-entry mechanism, can determine susceptibility to TRIM21. For example, the enveloped virus RSV, which sheds antibodies after membrane fusion, escapes detection. Some viruses such as the Picornaviridae (for example, rhinovirus), although nonenveloped, may avoid the cytoplasmic detection of capsid-bound antibodies by the manner with which they escape their endosome. Rhinovirus entry involves fusion of the viral capsid with the endosome, which results in a sizeselective pore through which viral genomic RNA is ejected 35 . Future research should ascertain whether the separation of capsid and RNA is sufficient for evasion of TRIM21-mediated neutralization and signaling. Pathogens may also have evolved specific antagonists that prevent the activation of or disable or degrade TRIM21.
The identification of intracellular antibody-bound pathogens as ligands for TRIM21 should help elucidate contradictory findings about negative regulation 18, 19 and positive regulation [20] [21] [22] of IRF activity by TRIM21. Differences in the activation of members of the IRF family can greatly influence cytokine production. For example, IRF5 and IRF3 compete for binding at the Il12b locus, with IRF5 activating and IRF3 suppressing activation 36, 37 . In this study, we observed the greatest activation of IRF5 after challenge with AdV-antibody complex and, accordingly, more IL-12 production. IL-12, along with other cytokines whose expression was substantially upregulated in this study (CXCL10, CCL4 and IFN-γ) probably bias T cell activation toward a T helper type 1 response. However, it is likely that simultaneous recognition of specific pathogens by TRIM21 and PRRs elicits the activation of different transcription-factor profiles and subsequent immune responses appropriate to the nature of the pathogen.
Our findings indicated that TRIM21 concurrently targets viruses for destruction and alerts the body to infection. Such dual signaling and effector ability is shared by TRIM5α, which is able to direct the retroviral capsid to the proteasome and activate innate immunity 12, 38 , but is distinct from the abilities of classic PRRs such as the TLRs, which do not themselves exert antimicrobial activity. TRIM21 and TRIM5α may therefore exemplify an emerging class of sensors of the innate immune system, of which other TRIM proteins and pathogenrestriction factors are likely candidates. There may be commonalities in the mechanisms used by TRIM21 and TRIM5α, but certain key differences are known to exist. For example, inhibition of the proteasome prevents neutralization by TRIM21 (ref. 6), whereas it does not relieve restriction by TRIM5α. Similarly, TRIM5α has a high rate of protein turnover, but exchange of the RING domain of TRIM5α with that of TRIM21 increases protein half-life considerably yet preserves antiretroviral activity 39 . Low rates of endogenous TRIM21 turnover have also been observed 6 , which indicates a potentially important phenotypic difference between the paralogs. Understanding differences such as these may be of value in determining the molecular mechanisms of TRIM activity. TRIM21-mediated signaling and neutralization may need to be considered during the development of viral vectors for vaccination. Preexisting humoral immunity to a vector may have consequences for the effectiveness of delivery and for the nature of the immunity conferred due to the combined activities of TRIM21. Preexisting humoral immunity to the AdV used in the STEP trial for immunization against components of human immunodeficiency virus type 1 resulted in qualitatively different human immunodeficiency virus-specific immune responses, with a substantial impairment to CD8 + T cell immunity 40, 41 . Furthermore, the safety of adenovirus vectors has been a cause for concern, given the robust innate immune responses and 'cytokine storms' witnessed in certain gene-therapy trails 42 . Understanding the role of TRIM21 in such responses may inform the strategies used to mitigate their effects. Finally, it may be feasible to advantageously exploit TRIM21-mediated detection of vectors to enhance or direct the nature of acquired immunity.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary information is available in the online version of the paper.
